A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate

PHASE2TerminatedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

October 30, 2012

Primary Completion Date

November 10, 2014

Study Completion Date

November 10, 2014

Conditions
InflammationRheumatoid Arthritis
Interventions
DRUG

NNC0109-0012

Administered subcutaneously (s.c., under the skin), once weekly.

DRUG

placebo

Administered subcutaneously (s.c., under the skin), once weekly.

Trial Locations (139)

161

Novo Nordisk Investigational Site, Rome

1070

Novo Nordisk Investigational Site, Anderlecht

1113

Novo Nordisk Investigational Site, Ciudad Autonoma Buenos Aires

1194

Novo Nordisk Investigational Site, Ciudad de Buenos Aires

1601

Novo Nordisk Investigational Site, Kiev

4000

Novo Nordisk Investigational Site, San Miguel de Tucumán

Novo Nordisk Investigational Site, Liège

5543

Novo Nordisk Investigational Site, Bad Kreuznach

6400

Novo Nordisk Investigational Site, Kiskunhalas

8500

Novo Nordisk Investigational Site, Kortrijk

11042

Novo Nordisk Investigational Site, Lake Success

14000

Novo Nordisk Investigational Site, Prague

16011

Novo Nordisk Investigational Site, Arenzano

16132

Novo Nordisk Investigational Site, Genova

19002

Novo Nordisk Investigational Site, Guadalajara

21018

Novo Nordisk Investigational Site, Vinnytsia

21029

Novo Nordisk Investigational Site, Vinnytsia

21740

Novo Nordisk Investigational Site, Hagerstown

22081

Novo Nordisk Investigational Site, Hamburg

28210

Novo Nordisk Investigational Site, Charlotte

28942

Novo Nordisk Investigational Site, Madrid

29009

Novo Nordisk Investigational Site, Málaga

29118

Novo Nordisk Investigational Site, Orangeburg

30119

Novo Nordisk Investigational Site, Krakow

31000

Novo Nordisk Investigational Site, Chihuahua City

34684

Novo Nordisk Investigational Site, Palm Harbor

35033

Novo Nordisk Investigational Site, Rennes

36011

Novo Nordisk Investigational Site, Poltava

37134

Novo Nordisk Investigational Site, Verona

38119

Novo Nordisk Investigational Site, Memphis

38130

Novo Nordisk Investigational Site, Échirolles

38305

Novo Nordisk Investigational Site, Jackson

39245

Novo Nordisk Investigational Site, Vogelsang-Gommern

41009

Novo Nordisk Investigational Site, Seville

41010

Novo Nordisk Investigational Site, Seville

41014

Novo Nordisk Investigational Site, Seville

44093

Novo Nordisk Investigational Site, Nantes

44600

Novo Nordisk Investigational Site, Guadalajara

44649

Novo Nordisk Investigational Site, Herne

45032

Novo Nordisk Investigational Site, Orléans

46010

Novo Nordisk Investigational Site, Valencia

46601

Novo Nordisk Investigational Site, South Bend

50139

Novo Nordisk Investigational Site, Florence

52064

Novo Nordisk Investigational Site, Aachen

59901

Novo Nordisk Investigational Site, Kalispell

60035

Novo Nordisk Investigational Site, Iesi

60528

Novo Nordisk Investigational Site, Frankfurt

61039

Novo Nordisk Investigational Site, Kharkiv

61176

Novo Nordisk Investigational Site, Kharkiv

61201

Novo Nordisk Investigational Site, Rock Island

62704

Novo Nordisk Investigational Site, Springfield

63117

Novo Nordisk Investigational Site, St Louis

64000

Novo Nordisk Investigational Site, Monterrey

Novo Nordisk Investigational Site, Monterrey N.L.

65026

Novo Nordisk Investigational Site, Odesa

67206

Novo Nordisk Investigational Site, Wichita

69104

Novo Nordisk Investigational Site, Zaporizhzhia

69600

Novo Nordisk Investigational Site, Zaporizhzhia

70601

Novo Nordisk Investigational Site, Lake Charles

73069

Novo Nordisk Investigational Site, Norman

76001

Novo Nordisk Investigational Site, Zlín

76018

Novo Nordisk Investigational Site, Ivano-Frankivsk

77008

Novo Nordisk Investigational Site, Houston

78200

Novo Nordisk Investigational Site, San Luis Potosí City

80230

Novo Nordisk Investigational Site, Culiacán

83045

Novo Nordisk Investigational Site, Donetsk

83114

Novo Nordisk Investigational Site, Donetsk

87102

Novo Nordisk Investigational Site, Albuquerque

90022

Novo Nordisk Investigational Site, Los Angeles

91045

Novo Nordisk Investigational Site, Luhansk

91786

Novo Nordisk Investigational Site, Upland

91942

Novo Nordisk Investigational Site, La Mesa

92646

Novo Nordisk Investigational Site, Huntington Beach

92870

Novo Nordisk Investigational Site, Placentia

115522

Novo Nordisk Investigational Site, Moscow

119049

Novo Nordisk Investigational Site, Moscow

150003

Novo Nordisk Investigational Site, Yaroslavl

185019

Novo Nordisk Investigational Site, Petrozavodsk

190068

Novo Nordisk Investigational Site, Saint Petersburg

193257

Novo Nordisk Investigational Site, Kemerovo

197341

Novo Nordisk Investigational Site, Saint Petersburg

210029

Novo Nordisk Investigational Site, Vinnytsia

214025

Novo Nordisk Investigational Site, Smolensk

355017

Novo Nordisk Investigational Site, Stavropol

620102

Novo Nordisk Investigational Site, Yekaterinburg

630008

Novo Nordisk Investigational Site, Novosibirsk

656024

Novo Nordisk Investigational Site, Barnaul

656055

Novo Nordisk Investigational Site, Barnaul

52401-2112

Novo Nordisk Investigational Site, Cedar Rapids

42701-2988

Novo Nordisk Investigational Site, Elizabethtown

07728

Novo Nordisk Investigational Site, Freehold

08755

Novo Nordisk Investigational Site, Toms River

11201-4326

Novo Nordisk Investigational Site, Brooklyn

75150-5615

Novo Nordisk Investigational Site, Mesquite

25801-2805

Novo Nordisk Investigational Site, Beckley

B 1900AXI

Novo Nordisk Investigational Site, Buenos Aires

B1878GEG

Novo Nordisk Investigational Site, Buenos Aires

C1425DUH

Novo Nordisk Investigational Site, Buenos Aires

CA1199ABB

Novo Nordisk Investigational Site, Buenos Aires

Unknown

Novo Nordisk Investigational Site, Ciudad Autonoma de Buenos Aire

C1204AAD

Novo Nordisk Investigational Site, Ciudad de Buenos Aires

S2000PBJ

Novo Nordisk Investigational Site, Rosario

ZC:5400

Novo Nordisk Investigational Site, San Juan

T4000BRD

Novo Nordisk Investigational Site, San Miguel de Tucumán

74110-120

Novo Nordisk Investigational Site, Saint Oeste

36010-570

Novo Nordisk Investigational Site, Juiz de Fora

80030-110

Novo Nordisk Investigational Site, Curitiba

01244-030

Novo Nordisk Investigational Site, São Paulo

04026-000

Novo Nordisk Investigational Site, Vila Clementino

04032-060

Novo Nordisk Investigational Site, Vila Clementino

78040.360

Novo Nordisk Investigational Site, Cuiaba Mount

80440-080

Novo Nordisk Investigational Site, Curitiba

22271-100

Novo Nordisk Investigational Site, Rio de Janeiro

01323-903

Novo Nordisk Investigational Site, São Paulo

04266-010

Novo Nordisk Investigational Site, São Paulo

05437-010

Novo Nordisk Investigational Site, São Paulo

602 00

Novo Nordisk Investigational Site, Brno

625 00

Novo Nordisk Investigational Site, Brno

748 01

Novo Nordisk Investigational Site, Hlučín

530 02

Novo Nordisk Investigational Site, Pardubice

128 50

Novo Nordisk Investigational Site, Prague

130 00

Novo Nordisk Investigational Site, Prague

148 00

Novo Nordisk Investigational Site, Prague

D-50937

Novo Nordisk Investigational Site, Koein

06100

Novo Nordisk Investigational Site, Mexico City

06700

Novo Nordisk Investigational Site, México

Novo Nordisk Investigational Site, Roma

03100

Novo Nordisk Investigational Site, Mexico City

07760

Novo Nordisk Investigational Site, Mexico City

C.P. 06700

Novo Nordisk Investigational Site, Mexico City

15-879

Novo Nordisk Investigational Site, Bialystok

81-384

Novo Nordisk Investigational Site, Gdynia

40-040

Novo Nordisk Investigational Site, Katowice

60-218

Novo Nordisk Investigational Site, Poznan

63-000

Novo Nordisk Investigational Site, Środa Wielkopolska

01-868

Novo Nordisk Investigational Site, Warsaw

04-141

Novo Nordisk Investigational Site, Warsaw

50-381

Novo Nordisk Investigational Site, Wroclaw

02232

Novo Nordisk Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01636843 - A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate | Biotech Hunter | Biotech Hunter